Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Br J Pharm Res
Melanotan-2 remains the only available pharmacological tool allowing the simultaneous study of the relative contributions of the four MCR receptors using selective antagonism protocols (HS024 for MC4R, JNJ-10229570 for MC3R, etc.)
For example, in one letter the following was flagged as offending language, despite not naming the branded products: Doctors frequently recommend Compounded Tirzepatide or Compounded Semaglutide, both of which are GLP-1 agonists with the same active ingredient as the brand name medications. In another letter, the only offending language was: Clinically proven weight loss treatments. The FDA said this language implies that [the sellers] products are the same as an FDA-approved product when they are not. Whats Next
This matters for clients across Florida
New indication strategies are most powerful when they expand a drug into a much larger patient population or when the new indication is clinically significant enough to justify premium pricing that erodes more slowly than the original indications market
US$ 23.33
US$ 22.56
US$ 22.88
